Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1820608-92-1 | 7-Bromo-1,2-dimethyl-5-(trifluoromethyl)benzimidiazole | AA00I0FH | MFCD28369612
1820665-48-2 | tert-Butyl 2-[4-(methoxycarbonyl)phenyl]pyridine-4-carboxylate | AA00I0NB | MFCD26523350
1820704-50-4 | 3-Chloro-1-(3-chloropyridin-4-yl)pyridin-4-one | AA00I0U2 | MFCD27936851
1820741-23-8 | tert-Butyl 3-(cyclopropylmethane)sulfonylazetidine-1-carboxylate | AA00I11V | MFCD28166410
183208-71-1 | 4-(Trimethylsilyl)-3-butyn-1-amine | AA00I1BY | MFCD14702527
1854056-69-1 | 3-Bromo-4-chloro-1-[(4-methoxyphenyl)methyl]-1h-pyrazolo[3,4-b]pyridine | AA00I1H4 | MFCD30531306
1881289-35-5 | 4-(benzyloxy)-2-(trifluoromethyl)phenol | AA00I1WZ | MFCD29044757
190966-44-0 | 2-Bromo-3-(4-(methylsulfonyl)phenyl)cyclopent-2-enone | AA00I2R1 | MFCD20266974
194804-92-7 | 4-Bromo-2-fluoro-3-methoxybenzoic acid | AA00I302 | MFCD06656802
195435-23-5 | Triphenylvalsartan | AA00I3B4 | MFCD08460102